A quantitative method for evaluating the degradation of biologic scaffold materials.
Scaffolds derived from naturally occurring extracellular matrix (ECM) have found extensive use in the fields of tissue engineering and regenerative medicine. Many of these scaffolds are designed to degrade rapidly as they are replaced by new host tissue. Other scaffolds are chemically crosslinked to slow the rate of degradation or add strength to the scaffold. Commercially available ECM scaffolds have considerable variability with regards to tissue origin and methods of processing, and little is known about their rate of degradation and the fate of their degradation products. A novel method is described herein to integrally label ECM with a radioactive isotope ((14)C). It was found that a number of tissues are efficiently labeled, including heart, liver, trachea, pancreas, small intestine, and urinary bladder tissue. Of the tissues analyzed, only spleen was not found to contain detectable levels of (14)C. The technique is extremely sensitive, accurate, and safe, but requires access to accelerator mass spectrometry, and is expensive and time consuming. This model represents the first described quantitative method to determine the rate of degradation for an ECM scaffold and to track the fate of the degradation products.
Gilbert
Thomas W
TW
McGowan Institute for Regenerative Medicine, University of Pittsburgh, 100 Technology Drive, Suite 200, Pittsburgh, PA 15219, USA.
Stewart-Akers
Ann M
AM
Badylak
Stephen F
SF
D000818:Animals; D001672:Biocompatible Materials / Q000378:metabolism*; D002250:Carbon Radioisotopes / Q000378:metabolism*; D005109:Extracellular Matrix / Q000378:metabolism* / Q000502:physiology; D007421:Intestine, Small / Q000166:cytology / Q000378:metabolism; D013552:Swine; D023822:Tissue Engineering / Q000379:methods*
D001672:Biocompatible Materials; D002250:Carbon Radioisotopes